{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:41:12Z","timestamp":1793047272063,"version":"4.5.0"},"reference-count":188,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.healun.2025.09.017","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T04:54:28Z","timestamp":1765860868000},"page":"e104-e128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Considerations for Endpoints in Lung Transplant Clinical Trials: An ISHLT Consensus Statement"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1422-8367","authenticated-orcid":false,"given":"John R.","family":"Greenland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9740-1246","authenticated-orcid":false,"given":"Michael","family":"Perch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieran","family":"Halloran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah J.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Morrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7826-9101","authenticated-orcid":false,"given":"Anna","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5677-0288","authenticated-orcid":false,"given":"Ciara M.","family":"Shaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P.","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0638-2586","authenticated-orcid":false,"given":"Stuart C.","family":"Sweet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3468-9251","authenticated-orcid":false,"given":"Robin","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shambhu","family":"Aryal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7108-3785","authenticated-orcid":false,"given":"Nicholas","family":"Avdimiretz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5753-5127","authenticated-orcid":false,"given":"Fay","family":"Burrows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0596-3434","authenticated-orcid":false,"given":"Daniel","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorella","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2331-5067","authenticated-orcid":false,"given":"Michael","family":"Combs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"de Perrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ran","family":"Dellgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3695-4637","authenticated-orcid":false,"given":"Joshua M.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Egan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2368-2933","authenticated-orcid":false,"given":"Patricia","family":"Ging","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David V.","family":"Glidden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3631-8873","authenticated-orcid":false,"given":"Martin","family":"Goddard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soma","family":"Jyothula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hrishikesh","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna M.","family":"Kwakkel-van Erp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibha","family":"Lama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3690-5891","authenticated-orcid":false,"given":"Nandor","family":"Marczin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tereza","family":"Martinu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0101-1081","authenticated-orcid":false,"given":"Megan L.","family":"Neely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1370-3771","authenticated-orcid":false,"given":"Scott M.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline M.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9598-3369","authenticated-orcid":false,"given":"Elizabeth N.","family":"Pavlisko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3836-411X","authenticated-orcid":false,"given":"Hans Henrik L.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5496-7749","authenticated-orcid":false,"given":"Nicolaus","family":"Schwerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Unmil","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Shashaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianne","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5962-2184","authenticated-orcid":false,"given":"Laurie D.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9656-5844","authenticated-orcid":false,"given":"Stijn","family":"Verleden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Verplancke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Zeevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie L.","family":"Todd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.healun.2025.09.017_bib1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.healun.2019.03.009","article-title":"Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLT","volume":"38","author":"Verleden","year":"2019","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2025.09.017_bib2","unstructured":"FDA-NIH Biomarker Working Group. BEST (Biomarkers, EndpointS, and other Tools) Resource [Internet]. Silver Spring (MD): Food and Drug Administration (US); 2016-. Reasonably Likely Surrogate Endpoint. 2017 Sep 25 [Updated 2020 Sep 23]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK453485\/."},{"key":"10.1016\/j.healun.2025.09.017_bib3","unstructured":"European Medicines Agency. (2006, July 27). Guideline on clinical trials in small populations (Doc. Ref. CHMP\/EWP\/83561\/2005). https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-clinical-trials-small-populations_en.pdf."},{"key":"10.1016\/j.healun.2025.09.017_bib4","unstructured":"European Medicines Agency. Guideline on clinical investigation of immunosuppressants for solid organ transplantation. 2009:CHMP\/EWP\/263148\/06."},{"issue":"2","key":"10.1016\/j.healun.2025.09.017_bib5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/TP.0000000000004270","article-title":"Biomarkers for chronic lung allograft dysfunction: ready for prime time?","volume":"107","author":"Verleden","year":"2023","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.healun.2025.09.017_bib6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12874-022-01526-8","article-title":"Adaptive treatment allocation and selection in multi-arm clinical trials: a Bayesian perspective","volume":"22","author":"Arjas","year":"2022","journal-title":"BMC Med Res Method"},{"key":"10.1016\/j.healun.2025.09.017_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jclinepi.2023.02.010","article-title":"Methodology and design of platform trials: a meta-epidemiological study","volume":"157","author":"Pitre","year":"2023","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.healun.2025.09.017_bib8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2147\/CLEP.S242097","article-title":"Synthetic and external controls in clinical trials - a primer for researchers","volume":"12","author":"Thorlund","year":"2020","journal-title":"Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.healun.2025.09.017_bib9","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s12325-019-01192-1","article-title":"Real-world data and randomised controlled trials: the Salford Lung Study","volume":"37","author":"Leather","year":"2020","journal-title":"Adv Ther"},{"issue":"3","key":"10.1016\/j.healun.2025.09.017_bib10","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.healun.2021.11.013","article-title":"The effect of the cystic fibrosis care center on outcomes after lung transplantation for cystic fibrosis","volume":"41","author":"Bush","year":"2022","journal-title":"J Heart Lung Transplant"},{"issue":"10","key":"10.1016\/j.healun.2025.09.017_bib11","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.healun.2017.07.021","article-title":"Report of the ISHLT Working Group on Primary Lung Graft Dysfunction, part I: Definition and grading-A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation","volume":"36","author":"Snell","year":"2017","journal-title":"J Heart lung Transpl: Publ Int Soc Heart Transpl"},{"issue":"12","key":"10.1016\/j.healun.2025.09.017_bib12","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.healun.2022.08.013","article-title":"Contemporary trends in PGD incidence, outcomes, and therapies","volume":"41","author":"Cantu","year":"2022","journal-title":"J Heart Lung Transpl"},{"issue":"15","key":"10.1016\/j.healun.2025.09.017_bib13","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJMoa1014597","article-title":"Normothermic ex vivo lung perfusion in clinical lung transplantation","volume":"364","author":"Cypel","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.healun.2025.09.017_bib14","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2021.5856","article-title":"Inhaled pulmonary vasodilator therapy in adult lung transplant: a randomized clinical trial","volume":"157","author":"Ghadimi","year":"2022","journal-title":"JAMA Surg"},{"key":"10.1016\/j.healun.2025.09.017_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106617","article-title":"Baseline lung allograft dysfunction in primary graft dysfunction survivors after lung transplantation","volume":"188","author":"Li","year":"2021","journal-title":"Respir Med"},{"issue":"24","key":"10.1016\/j.healun.2025.09.017_bib16","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.164603","article-title":"NKG2D receptor activation drives primary graft dysfunction severity and poor lung transplantation outcomes","volume":"7","author":"Calabrese","year":"2022","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.healun.2025.09.017_bib17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1055\/s-0033-1348474","article-title":"Primary graft dysfunction","volume":"34","author":"Suzuki","year":"2013","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.healun.2025.09.017_bib18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jtcvs.2010.09.009","article-title":"Short- and long-term outcomes of 1000 adult lung transplant recipients at a single center","volume":"141","author":"Kreisel","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"10.1016\/j.healun.2025.09.017_bib19","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.hrtlng.2016.07.010","article-title":"Primary graft dysfunction: long-term physical function outcomes among lung transplant recipients","volume":"45","author":"Armstrong","year":"2016","journal-title":"Heart Lung"},{"issue":"4","key":"10.1016\/j.healun.2025.09.017_bib20","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1513\/AnnalsATS.201311-388OC","article-title":"Cognitive function, mental health, and health-related quality of life after lung transplantation","volume":"11","author":"Cohen","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"10.1016\/j.healun.2025.09.017_bib21","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.healun.2022.12.014","article-title":"Primary graft dysfunction grade 3 following pediatric lung transplantation is associated with chronic lung allograft dysfunction","volume":"42","author":"Wong","year":"2023","journal-title":"J Heart Lung Transpl"},{"issue":"5","key":"10.1016\/j.healun.2025.09.017_bib22","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S2213-2600(18)30136-X","article-title":"Normothermic ex-vivo preservation with the portable Organ Care System Lung device for bilateral lung transplantation (INSPIRE): a randomised, open-label, non-inferiority, phase 3 study","volume":"6","author":"Warnecke","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"11","key":"10.1016\/j.healun.2025.09.017_bib23","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.healun.2023.06.019","article-title":"Time to extubation for lung transplant recipients represents a pragmatic end-point to guide the development of prognostic tests","volume":"42","author":"Sage","year":"2023","journal-title":"J Heart Lung Transpl"},{"issue":"3","key":"10.1016\/j.healun.2025.09.017_bib24","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jtcvs.2019.02.134","article-title":"Interobserver variability impairs radiologic grading of primary graft dysfunction after lung transplantation","volume":"158","author":"Schwarz","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1016\/j.healun.2025.09.017_bib25","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1378\/chest.12-1480","article-title":"Latent class analysis identifies distinct phenotypes of primary graft dysfunction after lung transplantation","volume":"144","author":"Shah","year":"2013","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.healun.2025.09.017_bib26","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.healun.2007.10.017","article-title":"Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection","volume":"26","author":"Stewart","year":"2007","journal-title":"J Heart Lung Transpl"},{"issue":"9","key":"10.1016\/j.healun.2025.09.017_bib27","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.healun.2009.04.022","article-title":"Acute cellular rejection is a risk factor for bronchiolitis obliterans syndrome independent of post-transplant baseline FEV1","volume":"28","author":"Burton","year":"2009","journal-title":"J Heart lung Transpl: Publ Int Soc Heart Transpl"},{"issue":"3","key":"10.1016\/j.healun.2025.09.017_bib28","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1600-6143.2011.03849.x","article-title":"Spirometrically significant acute rejection increases the risk for BOS and death after lung transplantation","volume":"12","author":"Davis","year":"2012","journal-title":"Am J Transpl"},{"issue":"3","key":"10.1016\/j.healun.2025.09.017_bib29","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1164\/ajrccm.159.3.9607099","article-title":"Analysis of risk factors for the development of bronchiolitis obliterans syndrome","volume":"159","author":"Husain","year":"1999","journal-title":"Am J Respir Crit care Med"},{"issue":"2","key":"10.1016\/j.healun.2025.09.017_bib30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1053-2498(01)00360-6","article-title":"Risk factors for bronchiolitis obliterans: a systematic review of recent publications","volume":"21","author":"Sharples","year":"2002","journal-title":"J Heart Lung Transpl"},{"issue":"1","key":"10.1016\/j.healun.2025.09.017_bib31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/ajt.15561","article-title":"The impact of first untreated subclinical minimal acute rejection on risk for chronic lung allograft dysfunction or death after lung transplantation","volume":"20","author":"Levy","year":"2020","journal-title":"Am J Transpl"},{"issue":"9","key":"10.1016\/j.healun.2025.09.017_bib32","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1164\/rccm.200302-165OC","article-title":"Association of minimal rejection in lung transplant recipients with obliterative bronchiolitis","volume":"170","author":"Hopkins","year":"2004","journal-title":"Am J Respir Crit care Med"},{"issue":"10","key":"10.1016\/j.healun.2025.09.017_bib33","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1097\/01.tp.0000181161.60638.fa","article-title":"The significance of a single episode of minimal acute rejection after lung transplantation","volume":"80","author":"Hachem","year":"2005","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.healun.2025.09.017_bib34","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1097\/00007890-200106270-00012","article-title":"Results of a randomized, prospective, multicenter trial of mycophenolate mofetil versus azathioprine in the prevention of acute lung allograft rejection","volume":"71","author":"Palmer","year":"2001","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.healun.2025.09.017_bib35","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1164\/rccm.201005-0775OC","article-title":"Comparison of sirolimus with azathioprine in a tacrolimus-based immunosuppressive regimen in lung transplantation","volume":"183","author":"Bhorade","year":"2011","journal-title":"Am J Respir Crit care Med"},{"issue":"10","key":"10.1016\/j.healun.2025.09.017_bib36","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.healun.2007.07.027","article-title":"A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation","volume":"26","author":"Hachem","year":"2007","journal-title":"J Heart lung Transpl: Publ Int Soc Heart Transpl"},{"issue":"4","key":"10.1016\/j.healun.2025.09.017_bib37","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1067\/mtc.2003.71","article-title":"Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial","volume":"125","author":"Zuckermann","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.healun.2025.09.017_bib38","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S2213-2600(23)00293-X","article-title":"Effect of once-per-day tacrolimus versus twice-per-day ciclosporin on 3-year incidence of chronic lung allograft dysfunction after lung transplantation in Scandinavia (ScanCLAD): a multicentre randomised controlled trial","volume":"12","author":"Dellgren","year":"2024","journal-title":"Lancet Respir Med"},{"issue":"4","key":"10.1016\/j.healun.2025.09.017_bib39","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/ajt.12630","article-title":"Bronchoalveolar lavage cell immunophenotyping facilitates diagnosis of lung allograft rejection","volume":"14","author":"Greenland","year":"2014","journal-title":"Am J Transpl"},{"issue":"3","key":"10.1016\/j.healun.2025.09.017_bib40","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.chest.2023.03.033","article-title":"BAL fluid eosinophilia associates with chronic lung allograft dysfunction risk: a multicenter study","volume":"164","author":"Todd","year":"2023","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.healun.2025.09.017_bib41","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1378\/chest.125.4.1224","article-title":"Transplant\/Immunology Network of the American College of Chest P. A survey of clinical practice of lung transplantation in North America","volume":"125","author":"Levine","year":"2004","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.healun.2025.09.017_bib42","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1111\/j.1600-6143.2005.00953.x","article-title":"Minimal acute rejection after lung transplantation: a risk for bronchiolitis obliterans syndrome","volume":"5","author":"Khalifah","year":"2005","journal-title":"Am J Transpl"},{"issue":"2","key":"10.1016\/j.healun.2025.09.017_bib43","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1600-6143.2010.03382.x","article-title":"Pathologic interpretation of transbronchial biopsy for acute rejection of lung allograft is highly variable","volume":"11","author":"Arcasoy","year":"2011","journal-title":"Am J Transpl"},{"issue":"6","key":"10.1016\/j.healun.2025.09.017_bib44","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.healun.2004.04.002","article-title":"Reliability for grading acute rejection and airway inflammation after lung transplantation","volume":"24","author":"Chakinala","year":"2005","journal-title":"J Heart Lung Transpl"},{"issue":"6","key":"10.1016\/j.healun.2025.09.017_bib45","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1378\/chest.12-2107","article-title":"Interobserver variability in grading transbronchial lung biopsy specimens after lung transplantation","volume":"143","author":"Bhorade","year":"2013","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.healun.2025.09.017_bib46","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.healun.2024.10.007","article-title":"Diagnostic alignment to optimize inter-rater reliability among lung transplant pathologists","volume":"44","author":"Pavlisko","year":"2025","journal-title":"J Heart Lung Transpl"},{"issue":"4","key":"10.1016\/j.healun.2025.09.017_bib47","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ajt.2023.10.022","article-title":"The 2022 Banff Meeting Lung Report","volume":"24","author":"Pavlisko","year":"2024","journal-title":"Am J Transpl"},{"issue":"4","key":"10.1016\/j.healun.2025.09.017_bib48","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.healun.2016.01.1223","article-title":"Antibody-mediated rejection of the lung: a consensus report of the International Society for Heart and Lung Transplantation","volume":"35","author":"Levine","year":"2016","journal-title":"J Heart Lung Transpl"},{"issue":"7","key":"10.1016\/j.healun.2025.09.017_bib49","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1111\/ajt.17028","article-title":"A pilot randomized controlled trial of de novo belatacept-based immunosuppression following anti-thymocyte globulin induction in lung transplantation","volume":"22","author":"Huang","year":"2022","journal-title":"Am J Transpl"},{"issue":"1","key":"10.1016\/j.healun.2025.09.017_bib50","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/ajt.16862","article-title":"CTOTC-08: a multicenter randomized controlled trial of rituximab induction to reduce antibody development and improve outcomes in pediatric lung transplant recipients","volume":"22","author":"Sweet","year":"2022","journal-title":"Am J Transpl"},{"issue":"3","key":"10.1016\/j.healun.2025.09.017_bib51","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1007\/s12325-020-01224-1","article-title":"Design and rationale of a Scandinavian Multicenter Randomized Study evaluating if once-daily tacrolimus versus twice-daily cyclosporine reduces the 3-year incidence of chronic lung allograft dysfunction after lung transplantation (ScanCLAD Study)","volume":"37","author":"Dellgren","year":"2020","journal-title":"Adv Ther"},{"issue":"12","key":"10.1016\/j.healun.2025.09.017_bib52","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1111\/tri.14153","article-title":"Outcomes with alemtuzumab induction therapy in lung transplantation: a comprehensive large-scale single-center analysis","volume":"34","author":"Benazzo","year":"2021","journal-title":"Transpl Int"},{"issue":"1","key":"10.1016\/j.healun.2025.09.017_bib53","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ajt.2022.11.013","article-title":"Clinical recommendations for posttransplant assessment of anti-HLA (Human Leukocyte Antigen) donor-specific antibodies: A Sensitization in Transplantation: Assessment of Risk consensus document","volume":"23","author":"Lefaucheur","year":"2023","journal-title":"Am J Transpl"},{"issue":"12","key":"10.1016\/j.healun.2025.09.017_bib54","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.healun.2022.08.014","article-title":"The molecular features of chronic lung allograft dysfunction in lung transplant airway mucosa","volume":"41","author":"Halloran","year":"2022","journal-title":"J Heart Lung Transpl"},{"issue":"10","key":"10.1016\/j.healun.2025.09.017_bib55","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.healun.2022.06.021","article-title":"Lung allograft standardized histological analysis (LASHA) template: a research consensus proposal","volume":"41","author":"Calabrese","year":"2022","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2025.09.017_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2024.12973","article-title":"Antibody-mediated rejection in lung transplantation: diagnosis and therapeutic armamentarium in a 21st century perspective","volume":"37","author":"Messika","year":"2024","journal-title":"Transpl Int"},{"issue":"5","key":"10.1016\/j.healun.2025.09.017_bib57","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.healun.2019.03.008","article-title":"Chronic lung allograft dysfunction: definition and update of restrictive allograft syndrome-a consensus report from the Pulmonary Council of the ISHLT","volume":"38","author":"Glanville","year":"2019","journal-title":"J Heart Lung Transpl"},{"issue":"8","key":"10.1016\/j.healun.2025.09.017_bib58","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","article-title":"Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement","volume":"200","author":"Graham","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.healun.2025.09.017_bib59","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.healun.2023.01.010","article-title":"Design and implementation of a digital health home spirometry intervention for remote monitoring of lung transplant function","volume":"42","author":"Odisho","year":"2023","journal-title":"J Heart Lung Transpl"},{"issue":"2","key":"10.1016\/j.healun.2025.09.017_bib60","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.healun.2018.10.006","article-title":"Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction","volume":"38","author":"Todd","year":"2019","journal-title":"J Heart Lung Transpl"},{"issue":"6","key":"10.1016\/j.healun.2025.09.017_bib61","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1183\/09031936.00107514","article-title":"An international ISHLT\/ATS\/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome","volume":"44","author":"Meyer","year":"2014","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.healun.2025.09.017_bib62","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.healun.2018.12.002","article-title":"Interrater agreement in the diagnosis of chronic lung allograft dysfunction after lung transplantation","volume":"38","author":"Fisher","year":"2019","journal-title":"J Heart lung Transpl: Publ Int Soc Heart Transpl"},{"issue":"6","key":"10.1016\/j.healun.2025.09.017_bib63","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1164\/ajrccm.161.6.9909092","article-title":"Bronchiolitis obliterans syndrome after lung transplantation and health-related quality of life","volume":"161","author":"van Den","year":"2000","journal-title":"Am J Respir Crit care Med"},{"issue":"7","key":"10.1016\/j.healun.2025.09.017_bib64","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.healun.2007.04.004","article-title":"Long-term survival after lung transplantation depends on development and severity of bronchiolitis obliterans syndrome","volume":"26","author":"Burton","year":"2007","journal-title":"J Heart lung Transpl: Publ Int Soc Heart Transpl"},{"issue":"5","key":"10.1016\/j.healun.2025.09.017_bib65","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/thoraxjnl-2014-205998","article-title":"A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation","volume":"70","author":"Corris","year":"2015","journal-title":"Thorax"},{"issue":"22","key":"10.1016\/j.healun.2025.09.017_bib66","first-page":"2083","article-title":"A Phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014"},{"issue":"9779","key":"10.1016\/j.healun.2025.09.017_bib67","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(11)60405-4","article-title":"Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials","volume":"377","author":"Noble","year":"2011","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.healun.2025.09.017_bib68","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1183\/09031936.04.00065004","article-title":"Lung transplant outcomes: a review of survival, graft function, physiology, health-related quality of life and cost-effectiveness","volume":"24","author":"Studer","year":"2004","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.healun.2025.09.017_bib69","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2217\/bmm-2021-1013","article-title":"Markers of rejection of a lung allograft: state of the art","volume":"16","author":"Silva","year":"2022","journal-title":"Biomark Med"},{"issue":"8","key":"10.1016\/j.healun.2025.09.017_bib70","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.21037\/jtd.2017.07.85","article-title":"Outcomes after lung transplantation","volume":"9","author":"Thabut","year":"2017","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.healun.2025.09.017_bib71","unstructured":"EMA. Patient experience data in EU medicines development and regulatory decision-making. Updated 10\/2022. Accessed 4\/25\/23, 2023. \u3008https:\/\/www.ema.europa.eu\/en\/documents\/other\/executive-summary-patient-experience-data-eu-medicines-development-regulatory-decision-making_en.pdf\u3009."},{"key":"10.1016\/j.healun.2025.09.017_bib72","unstructured":"FDA. FDA Patient-Focused Drug Development Guidance Series for Enhancing the Incorporation of the Patient\u2019s Voice in Medical Product Development and Regulatory Decision Making. Webpage. Updated 4\/6\/2023. Accessed 4\/25\/2023, \u3008https:\/\/www.fda.gov\/drugs\/development-approval-process-drugs\/fda-patient-focused-drug-development-guidance-series-enhancing-incorporation-patients-voice-medical\u3009."},{"key":"10.1016\/j.healun.2025.09.017_bib73","unstructured":"Mokkin L.B., Prinsen C.A., Patrick D.L., et al. COSMIN Study Design checklist for Patient-reported outcome measurement instruments. Updated July 2019. Accessed 4\/27\/2023, 2023. \u3008https:\/\/www.cosmin.nl\u3009."},{"issue":"6","key":"10.1016\/j.healun.2025.09.017_bib74","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s11136-014-0875-5","article-title":"Defining novel health-related quality of life domains in lung transplantation: a qualitative analysis","volume":"24","author":"Singer","year":"2015","journal-title":"Qual life Res: Int J Qual life Asp Treat, care Rehabil"},{"issue":"4","key":"10.1016\/j.healun.2025.09.017_bib75","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jval.2013.04.004","article-title":"Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force","volume":"16","author":"Matza","year":"2013","journal-title":"Value Health"},{"key":"10.1016\/j.healun.2025.09.017_bib76","doi-asserted-by":"crossref","DOI":"10.5888\/pcd14.170030","article-title":"Physical activity as a vital sign: a systematic review","volume":"14","author":"Golightly","year":"2017","journal-title":"Prev Chronic Dis"},{"issue":"8","key":"10.1016\/j.healun.2025.09.017_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9082450","article-title":"Novel input for designing patient-tailored pulmonary rehabilitation: telemonitoring physical activity as a vital sign-SMARTREAB Study","volume":"9","author":"Santos","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.healun.2025.09.017_bib78","article-title":"Design of Lung Transplant Go (LTGO): a randomized controlled trial evaluating the efficacy of a telerehabilitation behavioral exercise intervention to improve physical activity, physical function, and blood pressure control after lung transplantation","volume":"33","author":"Vendetti","year":"2023","journal-title":"Conte Clin Trials Commun"},{"issue":"3","key":"10.1016\/j.healun.2025.09.017_bib79","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000000979","article-title":"Remote therapy to improve outcomes in lung transplant recipients: design of the INSPIRE-III randomized clinical trial","volume":"6","author":"Blumenthal","year":"2020","journal-title":"Transpl Direct"},{"issue":"4","key":"10.1016\/j.healun.2025.09.017_bib80","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14236","article-title":"Mobile health technology to improve emergent frailty after lung transplantation","volume":"35","author":"Diamond","year":"2021","journal-title":"Clin Transplant"},{"issue":"3","key":"10.1016\/j.healun.2025.09.017_bib81","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol Ser A, Biol Sci Med Sci"},{"key":"10.1016\/j.healun.2025.09.017_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2023.02.006","article-title":"Development of the Lung Transplant Frailty Scale (LT-FS)","author":"Singer","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2025.09.017_bib83","article-title":"Considerations for assessing physical function and physical activity in clinical trials during the COVID-19 pandemic","volume":"105","author":"Moon","year":"2021","journal-title":"Conte Clin Trials"},{"key":"10.1016\/j.healun.2025.09.017_bib84","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.genhosppsych.2021.06.011","article-title":"Sleep quality, depressive symptoms, and transplant outcomes: follow-up analyses from the ADAPT prospective pilot study","volume":"72","author":"Smith","year":"2021","journal-title":"Gen Hosp Psychiatry"},{"issue":"11","key":"10.1016\/j.healun.2025.09.017_bib85","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13710","article-title":"Depressive symptoms, physical activity, and clinical events: the ADAPT prospective pilot study","volume":"33","author":"Smith","year":"2019","journal-title":"Clin Transplant"},{"issue":"7","key":"10.1016\/j.healun.2025.09.017_bib86","article-title":"Exercise training for adult lung transplant recipients","volume":"7","author":"Gutierrez-Arias","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.healun.2025.09.017_bib87","unstructured":"In:Cooper R., Snair M., Denning L.A., eds. Exploring the State of the Science of Solid Organ Transplantation and Disability: Proceedings of a Workshop. 2021."},{"key":"10.1016\/j.healun.2025.09.017_bib88","article-title":"Telerehabilitation using fitness application in patients with severe cystic fibrosis awaiting lung transplant: a pilot study","volume":"2021","author":"Layton","year":"2021","journal-title":"Int J Telemed Appl"},{"issue":"2","key":"10.1016\/j.healun.2025.09.017_bib89","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/CPT.0000000000000087","article-title":"A 1-month physical therapy-based outpatient program for adults awaiting lung transplantation: a retrospective analysis of exercise capacity, symptoms, and quality of life","volume":"30","author":"Byrd","year":"2019","journal-title":"Cardiopulm Phys Ther J"},{"issue":"1","key":"10.1016\/j.healun.2025.09.017_bib90","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/CPT.0000000000000174","article-title":"Condensed outpatient rehabilitation early after lung transplantation: a retrospective analysis of 6-minute walk distance and its predictors","volume":"33","author":"Byrd","year":"2022","journal-title":"Cardiopulm Phys Ther J"},{"issue":"6","key":"10.1016\/j.healun.2025.09.017_bib91","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13274","article-title":"A mobile health technology enabled home-based intervention to treat frailty in adult lung transplant candidates: A pilot study","volume":"32","author":"Singer","year":"2018","journal-title":"Clin Transpl"},{"key":"10.1016\/j.healun.2025.09.017_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2023.01.017","article-title":"Evaluation of frailty measures and short-term outcomes after lung transplantation","author":"Swaminathan","year":"2023","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.healun.2025.09.017_bib93","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001094","article-title":"Cumulative deficits frailty index predicts outcomes for solid organ transplant candidates","volume":"7","author":"Varughese","year":"2021","journal-title":"Transpl Direct"},{"issue":"5","key":"10.1016\/j.healun.2025.09.017_bib94","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1503\/cmaj.050051","article-title":"A global clinical measure of fitness and frailty in elderly people","volume":"173","author":"Rockwood","year":"2005","journal-title":"CMAJ"},{"issue":"9","key":"10.1016\/j.healun.2025.09.017_bib95","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.healun.2020.06.006","article-title":"Effect of high-intensity training on peak oxygen uptake and muscular strength after lung transplantation: A randomized controlled trial","volume":"39","author":"Ulvestad","year":"2020","journal-title":"J Heart Lung Transpl"},{"issue":"4","key":"10.1016\/j.healun.2025.09.017_bib96","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.pcad.2014.10.005","article-title":"The current state of physical activity assessment tools","volume":"57","author":"Ainsworth","year":"2015","journal-title":"Prog Cardiovasc Dis"},{"issue":"4","key":"10.1016\/j.healun.2025.09.017_bib97","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/17437199.2022.2046482","article-title":"White paper: open digital health - accelerating transparent and scalable health promotion and treatment","volume":"16","author":"Kwasnicka","year":"2022","journal-title":"Health Psychol Rev"},{"issue":"11","key":"10.1016\/j.healun.2025.09.017_bib98","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001385","article-title":"Relationship of exercise capacity, physical function, and frailty measures with clinical outcomes and healthcare utilization in lung transplantation: a scoping review","volume":"8","author":"Bourgeois","year":"2022","journal-title":"Transpl Direct"},{"key":"10.1016\/j.healun.2025.09.017_bib99","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jclinepi.2021.04.009","article-title":"Objectively measured physical activity is associated with frailty in community-dwelling older adults: a systematic review","volume":"137","author":"Tolley","year":"2021","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.healun.2025.09.017_bib100","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18010203","article-title":"Relationship between physical performance and frailty syndrome in older adults: the mediating role of physical activity, sedentary time and body composition","volume":"18","author":"Rodr\u00edguez-G\u00f3mez","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.healun.2025.09.017_bib101","article-title":"Patient-important outcomes in lung transplantation: a systematic review","volume":"81","author":"Weisenburger","year":"2022","journal-title":"Respir Med Res"},{"issue":"10","key":"10.1016\/j.healun.2025.09.017_bib102","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.healun.2019.08.001","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart-lung transplantation Report-2019; Focus theme: Donor and recipient size match","volume":"38","author":"Chambers","year":"2019","journal-title":"J Heart Lung Transpl: Publ Int Soc Heart Transpl"},{"issue":"12","key":"10.1016\/j.healun.2025.09.017_bib103","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1097\/00007890-200106270-00012","article-title":"Results of a randomized, prospective, multicenter trial of mycophenolate mofetil versus azathioprine in the prevention of acute lung allograft rejection","volume":"71","author":"Palmer","year":"2001","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.healun.2025.09.017_bib104","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1164\/rccm.201005-0775OC","article-title":"Comparison of sirolimus with azathioprine in a tacrolimus-based immunosuppressive regimen in lung transplantation","volume":"183","author":"Bhorade","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.healun.2025.09.017_bib105","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.healun.2007.07.027","article-title":"A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation","volume":"26","author":"Hachem","year":"2007","journal-title":"J Heart Lung Transpl: Publ Int Soc Heart Transpl"},{"issue":"4","key":"10.1016\/j.healun.2025.09.017_bib106","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1067\/mtc.2003.71","article-title":"Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial","volume":"125","author":"Zuckermann","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"7","key":"10.1016\/j.healun.2025.09.017_bib107","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1111\/ajt.17028","article-title":"A pilot randomized controlled trial of de novo belatacept-based immunosuppression following anti-thymocyte globulin induction in lung transplantation","volume":"22","author":"Huang","year":"2022","journal-title":"Am J Transpl: J Am Soc Transpl Am Soc Transpl Surg"},{"issue":"1","key":"10.1016\/j.healun.2025.09.017_bib108","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/ajt.16862","article-title":"CTOTC-08: a multicenter randomized controlled trial of rituximab induction to reduce antibody development and improve outcomes in pediatric lung transplant recipients","volume":"22","author":"Sweet","year":"2022","journal-title":"Am J Transpl: J Am Soc Transpl Am Soc Transpl Surg"},{"issue":"3","key":"10.1016\/j.healun.2025.09.017_bib109","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/0003-4975(95)00407-C","article-title":"Clinical trial of tacrolimus versus cyclosporine in lung transplantation","volume":"60","author":"Keenan","year":"1995","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"10.1016\/j.healun.2025.09.017_bib110","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S1053-2498(01)00244-3","article-title":"Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols","volume":"20","author":"Treede","year":"2001","journal-title":"J Heart Lung Transpl: Publ Int Soc Heart Transpl"},{"issue":"8","key":"10.1016\/j.healun.2025.09.017_bib111","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.healun.2012.03.008","article-title":"Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation","volume":"31","author":"Treede","year":"2012","journal-title":"J Heart Lung Transpl: Publ Int Soc Heart Transpl"},{"issue":"7","key":"10.1016\/j.healun.2025.09.017_bib112","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/01.tp.0000202755.33883.61","article-title":"Comparison of mycophenolate mofetil and azathioprine for prevention of bronchiolitis obliterans syndrome in de novo lung transplant recipients","volume":"81","author":"McNeil","year":"2006","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.healun.2025.09.017_bib113","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.healun.2014.06.001","article-title":"Three-year results of an investigator-driven multicenter, international, randomized open-label de novo trial to prevent BOS after lung transplantation","volume":"34","author":"Glanville","year":"2015","journal-title":"J Heart Lung Transpl: Publ Int Soc Heart Transpl"},{"issue":"11","key":"10.1016\/j.healun.2025.09.017_bib114","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1111\/ajt.13835","article-title":"Everolimus versus mycophenolate mofetil de novo after lung transplantation: a prospective, randomized, open-label trial","volume":"16","author":"Strueber","year":"2016","journal-title":"Am J Transpl: J Am Soc Transpl Am Soc Transpl Surg"},{"issue":"1","key":"10.1016\/j.healun.2025.09.017_bib115","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1600-6143.2005.01134.x","article-title":"Everolimus versus azathioprine in maintenance lung transplant recipients: an international, randomized, double-blind clinical trial","volume":"6","author":"Snell","year":"2006","journal-title":"Am J Transpl: J Am Soc Transpl Am Soc Transpl Surg"},{"issue":"6","key":"10.1016\/j.healun.2025.09.017_bib116","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1111\/ajt.15251","article-title":"A randomized trial of everolimus-based quadruple therapy vs standard triple therapy early after lung transplantation","volume":"19","author":"Gottlieb","year":"2019","journal-title":"Am J Transpl: J Am Soc Transpl Am Soc Transpl Surg"},{"issue":"9","key":"10.1016\/j.healun.2025.09.017_bib117","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1097\/TP.0000000000004095","article-title":"Five-year outcome of an early everolimus-based quadruple immunosuppression in lung transplant recipients: follow-up of the 4EVERLUNG Study","volume":"106","author":"Kneidinger","year":"2022","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.healun.2025.09.017_bib118","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.healun.2011.01.714","article-title":"Five-year outcomes with alemtuzumab induction after lung transplantation","volume":"30","author":"Shyu","year":"2011","journal-title":"J Heart Lung Transpl: Publ Int Soc Heart Transpl"},{"issue":"4","key":"10.1016\/j.healun.2025.09.017_bib119","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.healun.2011.01.701","article-title":"A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients","volume":"30","author":"Husain","year":"2011","journal-title":"J Heart Lung Transpl: Publ Int Soc Heart Transpl"},{"issue":"9","key":"10.1016\/j.healun.2025.09.017_bib120","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13642","article-title":"Foreword: 4th edition of the American Society of Transplantation Infectious Diseases Guidelines","volume":"33","author":"Green","year":"2019","journal-title":"Clin Transpl"},{"issue":"2","key":"10.1016\/j.healun.2025.09.017_bib121","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-6143.2005.01207.x","article-title":"AST ID Working Group on Infectious Disease Monitoring. American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation","volume":"6","author":"Humar","year":"2006","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.healun.2025.09.017_bib122","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13512","article-title":"Cytomegalovirus in solid organ transplant recipients - Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Razonable","year":"2019","journal-title":"Clin Transpl"},{"issue":"9","key":"10.1016\/j.healun.2025.09.017_bib123","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13507","article-title":"Urinary tract infections in solid organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Goldman","year":"2019","journal-title":"Clin Transpl"},{"issue":"9","key":"10.1016\/j.healun.2025.09.017_bib124","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13589","article-title":"AST ID Community of Practice. Surgical site infections: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Abbo","year":"2019","journal-title":"Clin Transpl"},{"issue":"9","key":"10.1016\/j.healun.2025.09.017_bib125","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13564","article-title":"AST ID Community of Practice. Management of Clostridioides (formerly Clostridium) difficile infection (CDI) in solid organ transplant recipients: Guidelines from the American Society of Transplantation Community of Practice","volume":"33","author":"Mullane","year":"2019","journal-title":"Clin Transplant"},{"issue":"9","key":"10.1016\/j.healun.2025.09.017_bib126","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13623","article-title":"AST Infectious Disease Community of Practice. Candida infections in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Aslam","year":"2019","journal-title":"Clin Transplant"},{"issue":"9","key":"10.1016\/j.healun.2025.09.017_bib127","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13587","article-title":"AST Infectious Diseases Community of Practice. Pneumocystis jiroveci in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Fishman","year":"2019","journal-title":"Clin Transplant"},{"issue":"9","key":"10.1016\/j.healun.2025.09.017_bib128","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13588","article-title":"AST Infectious Diseases Community of Practice. Management of infections due to nontuberculous mycobacteria in solid organ transplant recipients-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Longworth","year":"2019","journal-title":"Clin Transplant"},{"issue":"9","key":"10.1016\/j.healun.2025.09.017_bib129","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13513","volume":"33","author":"Subramanian","year":"2019","journal-title":"Clin Transpl"},{"issue":"3","key":"10.1016\/j.healun.2025.09.017_bib130","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1513\/AnnalsATS.202212-1019ST","article-title":"Immunocompromised host pneumonia: definitions and diagnostic criteria: an official American Thoracic Society Workshop Report","volume":"20","author":"Cheng","year":"2023","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"10.1016\/j.healun.2025.09.017_bib131","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-6143.2004.00692.x","article-title":"Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report","volume":"5","author":"Preiksaitis","year":"2005","journal-title":"Am J Transpl: J Am Soc Transpl Am Soc Transpl Surg"},{"issue":"1","key":"10.1016\/j.healun.2025.09.017_bib132","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/cid\/ciw668","article-title":"Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials","volume":"64","author":"Ljungman","year":"2017","journal-title":"Clin Infect Dis: Publ Infect Dis Soc Am"},{"issue":"6","key":"10.1016\/j.healun.2025.09.017_bib133","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/TP.0000000000002191","article-title":"The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation","volume":"102","author":"Kotton","year":"2018","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.healun.2025.09.017_bib134","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin inhibitor nephrotoxicity","volume":"4","author":"Naesens","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.healun.2025.09.017_bib135","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/j.ajkd.2021.10.014","article-title":"CKD in recipients of nonkidney solid organ transplants: a review","volume":"80","author":"Wiseman","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.healun.2025.09.017_bib136","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.healun.2011.08.016","article-title":"Short-term and long-term outcomes of acute kidney injury after lung transplantation","volume":"31","author":"Wehbe","year":"2012","journal-title":"J Heart Lung Transpl: Publ Int Soc Heart Transpl"},{"issue":"10","key":"10.1016\/j.healun.2025.09.017_bib137","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13678","article-title":"The association of post-lung transplant acute kidney injury with mortality is independent of primary graft dysfunction: a cohort study","volume":"33","author":"Shashaty","year":"2019","journal-title":"Clin Transpl"},{"issue":"1","key":"10.1016\/j.healun.2025.09.017_bib138","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1056\/NEJMra1214243","article-title":"Acute kidney injury and chronic kidney disease as interconnected syndromes","volume":"371","author":"Chawla","year":"2014","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.healun.2025.09.017_bib139","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/thoraxjnl-2019-213988","article-title":"Frailty after lung transplantation is associated with impaired health-related quality of life and mortality","volume":"75","author":"Venado","year":"2020","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.healun.2025.09.017_bib140","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1681\/ASN.2020091317","article-title":"The aftermath of AKI: recurrent AKI, acute kidney disease, and CKD progression","volume":"32","author":"Wen","year":"2021","journal-title":"J Am Soc Nephrol: JASN"},{"issue":"4","key":"10.1016\/j.healun.2025.09.017_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.trre.2022.100727","article-title":"Chronic kidney disease after lung transplantation in a changing era","volume":"36","author":"Grootjans","year":"2022","journal-title":"Transpl Rev (Orlando)"},{"issue":"3","key":"10.1016\/j.healun.2025.09.017_bib142","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1007\/s12325-020-01224-1","article-title":"Design and rationale of a Scandinavian multicenter randomized study evaluating if once-daily tacrolimus versus twice-daily cyclosporine reduces the 3-year incidence of chronic lung allograft dysfunction after lung transplantation (ScanCLAD Study)","volume":"37","author":"Dellgren","year":"2020","journal-title":"Adv Ther"},{"issue":"1","key":"10.1016\/j.healun.2025.09.017_bib143","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13063-020-04843-9","article-title":"Combined low-dose everolimus and low-dose tacrolimus after Alemtuzumab induction therapy: a randomized prospective trial in lung transplantation","volume":"22","author":"Benazzo","year":"2021","journal-title":"Trials"},{"issue":"4","key":"10.1016\/j.healun.2025.09.017_bib144","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nrneph.2017.2","article-title":"Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup","volume":"13","author":"Chawla","year":"2017","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"10.1016\/j.healun.2025.09.017_bib145","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/TP.0b013e3181cbac2d","article-title":"Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial","volume":"89","author":"Gullestad","year":"2010","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.healun.2025.09.017_bib146","first-page":"1","article-title":"Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury","volume":"2","author":"Kellum","year":"2012","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"10.1016\/j.healun.2025.09.017_bib147","first-page":"1","article-title":"Kidney disease: Improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Levin","year":"2013","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"10.1016\/j.healun.2025.09.017_bib148","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ki.2010.531","article-title":"Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes in both general and high-risk populations","volume":"80","author":"Gansevoort","year":"2011","journal-title":"Kidney Int"},{"issue":"4s","key":"10.1016\/j.healun.2025.09.017_bib149","first-page":"S117","article-title":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"issue":"19","key":"10.1016\/j.healun.2025.09.017_bib150","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin c-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.healun.2025.09.017_bib151","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1056\/NEJMoa2103753","article-title":"Race, genetic ancestry, and estimating kidney function in CKD","volume":"385","author":"Hsu","year":"2021","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.healun.2025.09.017_bib152","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Engels","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.healun.2025.09.017_bib153","article-title":"Malignancies after lung transplantation","volume":"37","author":"Stenman","year":"2024","journal-title":"Transpl Int"},{"issue":"1","key":"10.1016\/j.healun.2025.09.017_bib154","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/ajt.13925","article-title":"Risk factors for de novo malignancy following lung transplantation","volume":"17","author":"Magruder","year":"2017","journal-title":"Am J Transpl: J Am Soc Transpl Am Soc Transpl Surg"},{"issue":"11","key":"10.1016\/j.healun.2025.09.017_bib155","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.healun.2010.05.022","article-title":"Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients","volume":"29","author":"Vadnerkar","year":"2010","journal-title":"J Heart Lung Transpl: Publ Int Soc Heart Transpl"},{"issue":"1","key":"10.1016\/j.healun.2025.09.017_bib156","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jaad.2014.09.010","article-title":"Incidence and risk factors for skin cancer following lung transplantation","volume":"72","author":"Rashtak","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.healun.2025.09.017_bib157","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1055\/s-0041-1728798","article-title":"Skin Cancers and Lung Transplant","volume":"42","author":"Wilken","year":"2021","journal-title":"Semin Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.healun.2025.09.017_bib158","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.healun.2020.06.010","article-title":"Incidence and outcome of post-transplant lymphoproliferative disorders in lung transplant patients: Analysis of ISHLT Registry","volume":"39","author":"Zaffiri","year":"2020","journal-title":"J Heart Lung Transpl: Publ Int Soc Heart Transpl"},{"issue":"6","key":"10.1016\/j.healun.2025.09.017_bib159","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1097\/TP.0b013e318280b359","article-title":"Early major neurologic complications after lung transplantation: incidence, risk factors, and outcome","volume":"95","author":"Shigemura","year":"2013","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.healun.2025.09.017_bib160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174092","article-title":"Influence of early neurological complications on clinical outcome following lung transplant","volume":"12","author":"Gamez","year":"2017","journal-title":"PLOS ONE"},{"issue":"5","key":"10.1016\/j.healun.2025.09.017_bib161","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14275","article-title":"The association of post-operative delirium with patient-reported outcomes and mortality after lung transplantation","volume":"35","author":"DeBolt","year":"2021","journal-title":"Clin Transpl"},{"issue":"6","key":"10.1016\/j.healun.2025.09.017_bib162","doi-asserted-by":"crossref","first-page":"432","DOI":"10.14423\/SMJ.0000000000000663","article-title":"Association of white matter lesions, cerebral atrophy, intracranial extravascular calcifications, and ventricular-communicating hydrocephalus with delirium among veterans","volume":"110","author":"Detweiler","year":"2017","journal-title":"South Med J"},{"issue":"4","key":"10.1016\/j.healun.2025.09.017_bib163","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/j.1600-6143.2009.02998.x","article-title":"Neurological complications following adult lung transplantation","volume":"10","author":"Mateen","year":"2010","journal-title":"Am J Transpl: J Am Soc Transpl Am Soc Transpl Surg"},{"issue":"14","key":"10.1016\/j.healun.2025.09.017_bib164","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003173","article-title":"Calcineurin inhibitors associated posterior reversible encephalopathy syndrome in solid organ transplantation: report of 2 cases and literature review","volume":"95","author":"Song","year":"2016","journal-title":"Med (Baltim)"},{"issue":"2","key":"10.1016\/j.healun.2025.09.017_bib165","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3803\/EnM.2024.1939","article-title":"Bone loss after solid organ transplantation: a review of organ-specific considerations","volume":"39","author":"Kim","year":"2024","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"2014","key":"10.1016\/j.healun.2025.09.017_bib166","article-title":"Incidence of fractures after cardiac and lung transplantation: a single center experience","volume":"2014","author":"Hariman","year":"2014","journal-title":"J Osteoporos"},{"issue":"10","key":"10.1016\/j.healun.2025.09.017_bib167","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/01.TP.0000438619.96933.02","article-title":"Preoperative mild-to-moderate coronary artery disease does not affect long-term outcomes of lung transplantation","volume":"97","author":"Zanotti","year":"2014","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.healun.2025.09.017_bib168","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1053\/j.ajkd.2014.07.030","article-title":"GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration","volume":"64","author":"Levey","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.healun.2025.09.017_bib169","article-title":"The changing landscape of pediatric lung transplantation","volume":"36","author":"Avdimiretz","year":"2022","journal-title":"Rev Clin Transplant"},{"issue":"1","key":"10.1016\/j.healun.2025.09.017_bib170","doi-asserted-by":"crossref","first-page":"2201402","DOI":"10.1183\/13993003.01402-2022","article-title":"Lung transplantation for end-stage cystic fibrosis before and after the availability of elexacaftor\u2013tezacaftor\u2013ivacaftor, Germany, 2012\u20132021","volume":"61","author":"Ringshausen","year":"2023","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.healun.2025.09.017_bib171","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jacc.2021.05.039","article-title":"Pulmonary-to-systemic arterial shunt to treat children with severe pulmonary hypertension","volume":"78","author":"Grady","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.healun.2025.09.017_bib172","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/ajt.16862","article-title":"CTOTC-08: a multicenter randomized controlled trial of rituximab induction to reduce antibody development and improve outcomes in pediatric lung transplant recipients","volume":"22","author":"Sweet","year":"2022","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.healun.2025.09.017_bib173","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","article-title":"Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement","volume":"200","author":"Graham","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.healun.2025.09.017_bib174","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/ajt.14432","article-title":"Multiple breath washout in pediatric patients after lung transplantation","volume":"18","author":"Nyilas","year":"2018","journal-title":"Am J Transpl"},{"issue":"1","key":"10.1016\/j.healun.2025.09.017_bib175","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/ppul.26187","article-title":"Monitoring practices of chronic lung allograft dysfunction in pediatric lung transplantation","volume":"58","author":"Avdimiretz","year":"2023","journal-title":"Pedia Pulmonol"},{"issue":"12","key":"10.1016\/j.healun.2025.09.017_bib176","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1111\/ajt.15505","article-title":"Absence of evidence that respiratory viral infections influence pediatric lung transplantation outcomes: Results of the CTOTC-03 study","volume":"19","author":"Sweet","year":"2019","journal-title":"Am J Transpl"},{"issue":"8","key":"10.1016\/j.healun.2025.09.017_bib177","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/00005650-200108000-00006","article-title":"PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations","volume":"39","author":"Varni","year":"2001","journal-title":"Med Care"},{"issue":"3","key":"10.1016\/j.healun.2025.09.017_bib178","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/hec.4730020305","article-title":"The RAND 36-Item Health Survey 1.0","volume":"2","author":"Hays","year":"1993","journal-title":"Health Econ"},{"issue":"3","key":"10.1016\/j.healun.2025.09.017_bib179","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","article-title":"A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity","volume":"34","author":"Ware","year":"1996","journal-title":"Med Care"},{"issue":"5","key":"10.1016\/j.healun.2025.09.017_bib180","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/07853890109002087","article-title":"EQ-5D: a measure of health status from the EuroQol Group","volume":"33","author":"Rabin","year":"2001","journal-title":"Ann Med"},{"issue":"8","key":"10.1016\/j.healun.2025.09.017_bib181","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1164\/rccm.201806-1198OC","article-title":"Development and preliminary validation of the lung transplant quality of life (LT-QOL) Survey","volume":"199","author":"Singer","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.healun.2025.09.017_bib182","doi-asserted-by":"crossref","first-page":"E576","DOI":"10.1111\/ctr.12002","article-title":"A longitudinal study of patients' symptoms before and during the first year after lung transplantation","volume":"26","author":"Lanuza","year":"2012","journal-title":"Clin Transpl"},{"issue":"4","key":"10.1016\/j.healun.2025.09.017_bib183","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.healun.2003.12.013","article-title":"Quality of life after lung transplantation: a cross-sectional study","volume":"24","author":"Smeritschnig","year":"2005","journal-title":"J Heart Lung Transpl"},{"issue":"8","key":"10.1016\/j.healun.2025.09.017_bib184","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.healun.2015.03.005","article-title":"Development and psychometric properties of the Pulmonary-specific Quality-of-Life Scale in lung transplant patients","volume":"34","author":"Hoffman","year":"2015","journal-title":"J Heart Lung Transplant"},{"issue":"6","key":"10.1016\/j.healun.2025.09.017_bib185","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.129.6.1644","volume":"129","author":"Chen","year":"2006","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.healun.2025.09.017_bib186","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/thoraxjnl-2013-204557","article-title":"Development and validation of a lung transplant-specific disability questionnaire","volume":"69","author":"Singer","year":"2014","journal-title":"Thorax"},{"issue":"8","key":"10.1016\/j.healun.2025.09.017_bib187","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1513\/AnnalsATS.201612-1008OC","article-title":"Refining low physical activity measurement improves frailty assessment in advanced lung disease and survivors of critical illness","volume":"14","author":"Baldwin","year":"2017","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"10.1016\/j.healun.2025.09.017_bib188","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1513\/AnnalsATS.202212-1019ST","article-title":"Immunocompromised host pneumonia: definitions and diagnostic criteria: an official American Thoracic Society Workshop Report","volume":"20","author":"Cheng","year":"2023","journal-title":"Ann Am Thorac Soc"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249825022831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249825022831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T23:25:25Z","timestamp":1768605925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249825022831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":188,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1053249825022831"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2025.09.017","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Considerations for Endpoints in Lung Transplant Clinical Trials: An ISHLT Consensus Statement","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2025.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}